Ann Lab Med.  2023 Jan;43(1):1-2. 10.3343/alm.2023.43.1.1.

Recent Trends in Invasive Pneumococcal Disease in Korea in the Post-pneumococcal Vaccine Era

• Huh HJ
• Sung H

• KMID: 2551553
• DOI: http://doi.org/10.3343/alm.2023.43.1.1

Reference

1. de Miguel S, Domenech M, González-Camacho F, Sempere J, Vicioso D, Sanz JC, et al. 2021; Nationwide trends of invasive pneumococcal disease in Spain from 2009 through 2019 in children and adults during the pneumococcal conjugate vaccine era. Clin Infect Dis. 73:e3778–87. DOI: 10.1093/cid/ciaa1483. PMID: 32990303.

2. Grant LR, Slack MPE, Theilacker C, Vojicic J, Dion S, Reinert RR, et al. Distribution of serotypes causing invasive pneumococcal disease in children from high-income countries and the impact of pediatric pneumococcal vaccination. Clin Infect Dis. 2022; ciac475. DOI: 10.1093/cid/ciac475. PMID: 35789262.

3. Zhou M, Wang Z, Zhang L, Kudinha T, An H, Qian C, et al. 2022; Serotype distribution, antimicrobial susceptibility, multilocus sequencing type and virulence of invasive Streptococcus pneumoniae in China: a six-year multicenter study. Front Microbiol. 12:798750. DOI: 10.3389/fmicb.2021.798750. PMID: 35095809. PMCID: PMC8793633.

4. Yun KW, Rhie K, Kang JH, Kim KH, Ahn JG, Kim YJ, et al. 2021; Emergence of serotype 10A-ST11189 among pediatric invasive pneumococcal diseases, South Korea, 2014-2019. Vaccine. 39:5787–93. DOI: 10.1016/j.vaccine.2021.08.072. PMID: 34465475.

5. Kakuta R, Nakano R, Yano H, Ozawa D, Ohta N, Matsuoka T, et al. 2020; First two cases of infected aortic aneurysm caused by non-vaccine Streptococcus pneumoniae serotype 23A. Ann Lab Med. 40:270–3. DOI: 10.3343/alm.2020.40.3.270. PMID: 31858770. PMCID: PMC6933064.

6. Ouldali N, Levy C, Varon E, Bonacorsi S, Béchet S, Cohen R, et al. 2018; Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey. Lancet Infect Dis. 18:983–91. DOI: 10.1016/S1473-3099(18)30349-9. PMID: 30049623.

7. Lo SW, Gladstone RA, van Tonder AJ, Lees JA, du Plessis M, Benisty R, et al. 2019; Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect Dis. 19:759–69. DOI: 10.1016/S1473-3099(19)30297-X. PMID: 31196809. PMCID: PMC7641901.

8. Bajema KL, Gierke R, Farley MM, Schaffner W, Thomas A, Reingold AL, et al. Impact of pneumococcal conjugate vaccines on antibiotic-nonsusceptible invasive pneumococcal disease in the United States. J Infect Dis. 2022; jiac154. DOI: 10.1093/infdis/jiac154. PMID: 35481950.

9. Kim GR, Kim EY, Kim SH, Lee HK, Lee J, Shin JH, et al. 2023; Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive pneumococcal disease in Korea between 2017 and 2019 after introduction of the 13-valent pneumococcal conjugate vaccine. Ann Lab Med. 43:45–54. DOI: 10.3343/alm.2023.43.1.45. PMID: 36045056.

10. Park DC, Kim SH, Yong D, Suh IB, Kim YR, Yi J, et al. 2019; Serotype distribution and antimicrobial resistance of invasive and noninvasive Streptococcus pneumoniae isolates in Korea between 2014 and 2016. Ann Lab Med. 39:537–44. DOI: 10.3343/alm.2019.39.6.537. PMID: 31240881. PMCID: PMC6660335.

11. Sohn S, Hong K, Chun BC. 2020; Evaluation of the effectiveness of pneumococcal conjugate vaccine for children in Korea with high vaccine coverage using a propensity score matched national population cohort. Int J Infect Dis. 93:146–50. DOI: 10.1016/j.ijid.2020.01.034. PMID: 31982620.